Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer Lew currently holds 250,000 shares of ADURO BIOTECH, INC. (ADRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Lew has been a net seller of ADRO stock. They have purchased $68.0K and sold $2.0M worth of shares.
Jennifer Lew's most recent insider trade was on Feb 19, 2026, when they sold 250,000 shares at $0.00 per share.
Jennifer Lew serves as Executive at ADURO BIOTECH, INC. (ADRO). They have executed 74 insider transactions totaling $2.1M over their tenure at the company.
Jennifer Lew holds the position of Executive at ADURO BIOTECH, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Jennifer Lew has shown a selling trading pattern, with $68.0K in total purchases and $2.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jennifer Lew was on May 27, 2021, when they sold $77.8K worth of ANNX shares. This transaction involved 3,500 shares at $22.24 per share.
Jennifer Lew currently owns 250,000 shares of ADURO BIOTECH, INC. (ADRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer Lew's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer Lew has 74 Form 4 filings on record as an insider at ADURO BIOTECH, INC..
Set alerts for Jennifer Lew and 40,000+ other insiders.